Target Product Profiles: Physician Insights on Key Attributes - Psoriasis, A systemic agent that induces 75% improvement in PASI scores at 12 weeks in at least 30% more patients than etanercept for the treatment of psoriasis.

Table of Contents

• Introduction
  • Using Target Product Profi les in Your Market Strategy
  • Report Contents
  • Target Product Profi le Methodology
• Etiology and Pathophysiology
  • Overview
  • Pathophysiology
    • Clinical Features
    • Histological Features
    • Other Factors That May Be Involved in the Pathogenesis of Psoriasis
  • Etiology
    • Risk Factors
• Target Product Profi le Discussion-Psoriasis
  • Target Product Profi le Summary for Psoriasis-2011
  • Assessing Drug Development Opportunities
  • Physician Survey Results
    • Effi cacy
    • Safety and Tolerability
    • Delivery
    • Estimated Patient Share
  • Pricing Potential
  • Forecasted 2016 Pricing Environment
  • Competitors to Watch
  • Emerging Product Profi les